NEW YORK - Imagine using your cellphone to control the activity of your own cells to treat injuries and disease. It sounds like something from the imagination of an overly optimistic science fiction writer. But this may one day be a possibility through the emerging field of quantum biology. Over the past few decades, scientists
The awareness of DNA has revolutionized modern life – both in terms of the discovery of the double helix molecular structure that determines individual genetic codes and patterns in a unique arrangement in every single human being and animal, as well as what can be done with it. With that being said, here are the
BEER-SHEVA, Israel – An end-to-end cyber-biological attack, in which unwitting biologists may be tricked into generating dangerous toxins in their labs, has been discovered by Ben-Gurion University of the Negev cyber-researchers. According to a new paper just published in Nature Biotechnology, it is currently believed that a criminal needs to have physical contact with a
ANN ARBOR—Swift Biosciences, Inc., a developer of DNA and RNA library preparation kits, announced the launch of a new ACE2 Swift Normalase Amplicon Panel to further research on the main functional receptor for viral entry of coronavirus. Human ACE2 has been identified as a key receptor for SARS-CoV-2 host cell entry. The study of the
ANN ARBOR – Genomenon has announced version 1.3 of its Mastermind genomic search engine that adds new tools to help clinicians quickly find authoritative research related to their patients genomic mutations and a new suite of solutions to help automate next generation DNA sequencing workflows. While the cost of DNA sequencing continues to drop faster
NEW YORK - Cancer is caused by mistakes in DNA, and a new study finds that in most cancer cases, these mistakes are completely random; they're not due to heredity or environmental factors, but rather the result of random errors. The mistakes, or mutations, cause cancer to happen because even a tiny error in DNA
ANN ARBOR - Rubicon Genomics announced Monday a new agreement with Beckman Coulter Life Sciences for distribution of its ThruPLEX Plasma-seq kits for research applications. It follows an announcement last fall that the kit has been automated for use with Beckman Coulter’s Biomek FX Automated Workstation, an automated liquid handling solution for laboratories worldwide. Further
